Sphingoid Base Diversity
- PMID: 39824719
- DOI: 10.1016/j.atherosclerosis.2024.119091
Sphingoid Base Diversity
Abstract
Sphingolipids (SL) are crucial components of cellular membranes and play pivotal roles in various biological processes, including cell growth, differentiation, apoptosis, and stress responses. All SL contain a sphingoid base (SPB) backbone which is the shared and class-defining element. SPBs are heterogeneous in length and structure. This review summarizes our current understanding on minor SPBs and the role of the serine palmitoyltransferase (SPT) in particular of its subunits SPTLC3 and SPTSSA/B in forming a spectrum of structurally and metabolically distinct SPBs. Some minor SPBs, such as 1-deoxysphingolipids (1-deoxySL) are neurotoxic and associated with neurological disorders such as hereditary sensory neuropathy type 1 (HSAN1) and diabetic neuropathy. Furthermore, the review discusses the pathological implications of atypical SPBs in cardiometabolic conditions such as obesity, type 2 diabetes or cardiomyopathy, where the induction of the SPTLC3 subunit alters the SPB profile and contributes to disease progression. Understanding these, often neglected aspects of the sphingolipid metabolism provides potential therapeutic targets for metabolic and neurodegenerative diseases, emphasizing the need for continued research in this area.
Keywords: FADS3; Long chain base; SPTLC3; Serine-palmitoyltransferase; Sphingoid base; Sphingolipids.
Copyright © 2024 The Author. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Thorsten Hornemann reports financial support was provided by Swiss National Foundation (SNF). If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.Circulation. 2024 Aug 20;150(8):622-641. doi: 10.1161/CIRCULATIONAHA.123.066879. Epub 2024 Apr 25. Circulation. 2024. PMID: 38660786
-
The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases.J Biol Chem. 2009 Sep 25;284(39):26322-30. doi: 10.1074/jbc.M109.023192. Epub 2009 Aug 1. J Biol Chem. 2009. PMID: 19648650 Free PMC article.
-
Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases.Adv Exp Med Biol. 2022;1372:47-56. doi: 10.1007/978-981-19-0394-6_4. Adv Exp Med Biol. 2022. PMID: 35503173 Review.
-
Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.J Biol Chem. 2013 May 10;288(19):13397-409. doi: 10.1074/jbc.M112.428185. Epub 2013 Mar 25. J Biol Chem. 2013. PMID: 23530041 Free PMC article.
-
Serine Palmitoyltransferase (SPT)-related Neurodegenerative and Neurodevelopmental Disorders.J Neuromuscul Dis. 2024;11(4):735-747. doi: 10.3233/JND-240014. J Neuromuscul Dis. 2024. PMID: 38788085 Free PMC article. Review.
Cited by
-
Plasma lipidomic analysis reveals distinct lipid alterations in patients with pulmonary tuberculosis.Eur J Med Res. 2025 Jul 3;30(1):566. doi: 10.1186/s40001-025-02835-6. Eur J Med Res. 2025. PMID: 40611333 Free PMC article.
-
Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets.Cardiovasc Res. 2025 Aug 14;121(9):1345-1358. doi: 10.1093/cvr/cvaf093. Cardiovasc Res. 2025. PMID: 40460239 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources